在Charcot-Marie-Tooth疾病中的临床结果评估和生物标志物
Brett A McCray1, Vera Fridman1
1From the Department of Neurology (B.A.M.), University of Michigan Medical School, Ann Arbor; and Department of Neurology (V.F.), University of Colorado Anschutz Medical Campus, Aurora.
Neurology
|November 25, 2024
概括
查洛特玛丽牙病 (CMT) 研究正在推进,重点是新的临床结果评估 (COA) 和生物标志物,以跟踪疾病进展并评估这种常见的遗传神经病变的治疗方法.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 临床试验 临床试验
背景情况:
- 查洛-玛丽-牙病 (CMT) 是最常见的遗传性神经病变,目前没有修改疾病的治疗方法.
- 开发有效的治疗方法需要强大的临床结果评估 (COA) 和生物标志物.
研究的目的:
- 审查过去二十年来在开发和验证CMT的COA和生物标志物的挑战和成功.
- 突出结果测量的演变以及在CMT临床试验中客观生物标志物的日益增长的需求.
主要方法:
- 对自然史研究和已完成的CMT临床试验的审查.
- 早期临床尺度的局限性分析和新的,心理测量支持的尺度的发展.
- 评估新出现的客观生物标志物,包括MRI肌肉脂肪分数和血清标志物.
主要成果:
- 早期的CMT尺度表现出局限性;新的尺度如CMT神经病症评分版本2和CMT儿科尺度已经开发出来.
- 肌肉脂肪分数是MRI响应的生物标志物,但其功能相关性需要进一步研究.
- 像神经丝光这样的血清生物标志物可靠地区分CMT患者,但需要验证治疗响应.
结论:
- 目前正在进行的临床试验正在测试CMT的有前途的COA和生物标志物.
- 建立最佳的结合结果测量和生物标志物对于推进CMT疗法至关重要.
- 解决患者选择和招生问题对于即将在CMT中进行的疾病修饰治疗试验的成功至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
773
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773


